Please assess the completion status of the following clinical trial:

Trial Title: Diagnostic Outcome Trial in Heart Failure (DOT-HF Trial)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects of both genders with mild to severe HF as defined as NHYA Class II to IV who also have an indication for device implant according to ESC/AHA guidelines as well as having a HF hospitalization or Emergency Department visit necessitating therapy within the past 12 months and who meet all inclusion criteria and no exclusion criteria, are eligible for this study.~Exclusion Criteria:~* Subject is post heart transplant or actively listed on the transplant list and reasonable probability (as defined by investigator) of undergoing transplantation in the next year~* Subject received a coronary artery bypass graft or valve surgery in last 90 days~* Subject with a myocardial infarction (MI) in the last 40 days.~* Subject's life expectancy is less than one year in the opinion of the physician~* Subject has severe Chronic Obstructive Pulmonary Disease (COPD), as determined by physician and documented in medical records~* Subject is listed for valve replacement/valve repair~* Subject has severe, primary pulmonary hypertension as determined by physician and documented in medical records~* Subject with serum creatinine ≥ 2.5 mg/dL measured within 14 days prior to enrolment~* Subject on chronic renal dialysis~* Subject on continuous or uninterrupted (≥ 2 stable infusions per week) infusion (inotropic) therapy for HF~* Subject has complex and uncorrected Congenital Heart Disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Access Arm (Type: EXPERIMENTAL): HF subjects managed with standard clinical assessment and using the audible OptiVol® Fluid status monitoring alert and the device Cardiac Compass Report
- Control arm (Type: ACTIVE_COMPARATOR): HF subjects managed with standard clinical assessment

Based on this trial design, predict the completion outcome and termination type (if applicable).